# A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

> **NCT01176240** · PHASE3 · COMPLETED · sponsor: **Chelsea Therapeutics** · enrollment: 225 (actual)

## Conditions studied

- Orthostatic Hypotension
- Parkinson's Disease

## Interventions

- **DRUG:** Droxidopa
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01176240
- **Lead sponsor:** Chelsea Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-10
- **Final completion:** 2012-11
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01176240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01176240, "A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01176240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*